Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The endoscopic grading system (EGGIM) has been widely used to assess the extent of gastric intestinal metaplasia during endoscopy. Investigators developed an artificial intelligence (AI) system to automatically evaluate the extent of gastric intestinal metaplasia (GIM) and calculate the EGGIM scores in endoscopy examination. This study is a prospective, multi-center study aimed at exploring the performance and reliability of AI-EGGIM scoring. This is a prospective study designed to validate the AI-EGGIM system in a larger cohort. The study protocol was developed based on preliminary experience from a prior investigation (NCT05464108).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 75
View:

• patients aged 40-75 years who undergo the IEE examination

• patients who voluntarily sign the informed consent form

Locations
Other Locations
China
Qilu Hospital of Shandong University
RECRUITING
Jinan
Shandong First Medical University First Affiliated Hospital
NOT_YET_RECRUITING
Jinan
Shandong Second Provincial General Hospital
NOT_YET_RECRUITING
Jinan
Time Frame
Start Date: 2025-11-01
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 3000
Related Therapeutic Areas
Sponsors
Leads: Qilu Hospital of Shandong University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials